BAF312, a Selective Sphingosine 1-Phosphate Receptor Modulator, Effectively Suppresses MRI Lesion Activity in Relapsing-Remitting Multiple Sclerosis: Findings of an Adaptive Dose-Ranging Phase 2 Study
MULTIPLE SCLEROSIS JOURNAL（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要